Does the use of recombinant erythropoietin for the treatment of chemotherapy-induced anemia in patients with ovarian cancer affect progression-free or overall survival?
The current results indicated that there was no difference in cancer-related PFS or OS with use of ESA in this cohort of women treated for ovarian cancer.
Older adults with abnormal serum lipoproteins are at increased risk of developing hypertension. Clinical trials exploring the effects of the modification of lipoprotein levels on hypertension incidence rates are needed.